X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61083) 61083
Newspaper Article (10999) 10999
Book Chapter (669) 669
Newsletter (585) 585
Book / eBook (294) 294
Conference Proceeding (193) 193
Dissertation (183) 183
Magazine Article (102) 102
Reference (56) 56
Publication (51) 51
Government Document (31) 31
Journal / eJournal (29) 29
Trade Publication Article (23) 23
Web Resource (10) 10
Book Review (8) 8
Report (5) 5
Paper (2) 2
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
polypeptides (31599) 31599
animals (23023) 23023
humans (19446) 19446
proteins (13705) 13705
biochemistry & molecular biology (11717) 11717
male (11523) 11523
female (8390) 8390
polypeptide (7960) 7960
rats (7763) 7763
amino acid sequence (6699) 6699
molecular sequence data (6460) 6460
peptides (6141) 6141
inventors (5863) 5863
mice (5577) 5577
research (5310) 5310
amino acids (5193) 5193
endocrinology & metabolism (5044) 5044
analysis (4675) 4675
expression (4530) 4530
vasoactive intestinal polypeptide (4479) 4479
neurosciences (4324) 4324
adult (4274) 4274
cell biology (4197) 4197
pharmacology & pharmacy (4095) 4095
middle aged (3490) 3490
enzymes (3425) 3425
protein (3365) 3365
gene expression (3252) 3252
biophysics (3169) 3169
physiology (3149) 3149
physiological aspects (3041) 3041
immunohistochemistry (2966) 2966
insulin (2918) 2918
multidisciplinary sciences (2866) 2866
kinetics (2664) 2664
identification (2657) 2657
cells (2638) 2638
islet amyloid polypeptide (2603) 2603
base sequence (2558) 2558
research article (2442) 2442
peptides - chemistry (2433) 2433
chemistry, multidisciplinary (2364) 2364
models, molecular (2356) 2356
protein conformation (2281) 2281
aged (2276) 2276
peptide (2257) 2257
pituitary adenylate cyclase-activating polypeptide (2254) 2254
diabetes (2227) 2227
glucose (2225) 2225
protein binding (2188) 2188
life sciences (2155) 2155
biochemistry (2132) 2132
secretion (2120) 2120
genes (2108) 2108
protein folding (2089) 2089
cancer (2079) 2079
mutation (2077) 2077
cyclase-activating polypeptide (2074) 2074
cells, cultured (2045) 2045
rat (2015) 2015
binding (2012) 2012
biology (1986) 1986
binding sites (1924) 1924
cell line (1914) 1914
glucagon-like peptide-1 (1895) 1895
rats, sprague-dawley (1869) 1869
antigens (1859) 1859
methods (1853) 1853
medicine (1824) 1824
rodents (1816) 1816
chemistry, physical (1807) 1807
insulin - metabolism (1766) 1766
molecular weight (1759) 1759
in-vitro (1728) 1728
immunology (1727) 1727
time factors (1710) 1710
apoptosis (1694) 1694
receptors (1688) 1688
metabolism (1685) 1685
plant sciences (1673) 1673
protein structure, secondary (1641) 1641
oncology (1622) 1622
chemistry (1619) 1619
signal transduction (1615) 1615
gene (1614) 1614
dose-response relationship, drug (1599) 1599
science (1597) 1597
genetic aspects (1595) 1595
rats, wistar (1595) 1595
insulin - blood (1593) 1593
biotechnology & applied microbiology (1572) 1572
cloning (1557) 1557
glucagon (1554) 1554
escherichia-coli (1549) 1549
brain (1546) 1546
polymer science (1524) 1524
medicine, research & experimental (1518) 1518
gene-expression (1516) 1516
health aspects (1514) 1514
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (141) 141
UofT at Mississauga - Stacks (30) 30
Collection Dvlpm't (Acquisitions) - Vendor file (17) 17
Gerstein Science - Periodical Stacks (15) 15
Chemistry (A D Allen) - Stacks (11) 11
UTL at Downsview - May be requested (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Online Resources - Online (8) 8
UofT at Scarborough - Stacks (7) 7
Gerstein Science - Bindery (5) 5
Earth Sciences (Noranda) - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (3) 3
Trinity College (John W Graham) - Stacks (3) 3
UofT at Scarborough - Withdrawn (2) 2
Chemistry (A D Allen) - Periodical Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Missing (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (73022) 73022
Japanese (1043) 1043
Chinese (280) 280
German (255) 255
French (186) 186
Russian (135) 135
Spanish (77) 77
Polish (69) 69
Korean (39) 39
Italian (33) 33
Czech (20) 20
Portuguese (17) 17
Hungarian (14) 14
Dutch (9) 9
Croatian (6) 6
Slovak (5) 5
Swedish (5) 5
Bulgarian (3) 3
Danish (3) 3
Serbian (3) 3
Turkish (3) 3
Finnish (2) 2
Greek (1) 1
Hebrew (1) 1
Latin (1) 1
Ndonga (1) 1
Norwegian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Soft Matter, ISSN 1744-683X, 12/2014, Volume 11, Issue 2, pp. 422 - 422
Correction for 'Phase behaviour and complex coacervation of aqueous polypeptide solutions' by Dimitrios Priftis et al. , Soft Matter , 2012, 8 , 9396-9405. 
Polypeptides
Journal Article
Nature materials, ISSN 1476-4660, 2018, Volume 17, Issue 12, pp. 1164 - 1164
In the version of this Article originally published, one of the authors' names was incorrectly given as Jeffery Schaal; it should have been Jeffrey L. Schaal.... 
Polypeptides
Journal Article
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 04/2011, Volume 17, Issue 10, pp. 1002 - 1024
In neurological insults, such as cerebral ischemia and traumatic brain injury, complex molecular mechanisms involving inflammation and apoptosis are known to... 
G protein-coupled receptor | Neuroprotection | Stroke | Bioactive conformation | Traumatic brain injury | PACAP | Peptide drug design | VIP | CYCLASE-ACTIVATING POLYPEPTIDE | VASOACTIVE-INTESTINAL-PEPTIDE | BLOOD-BRAIN-BARRIER | CEREBELLAR GRANULE CELLS | HUMAN-SERUM-ALBUMIN | GLUCAGON-LIKE PEPTIDE-1 | PROTEIN-COUPLED RECEPTOR | N-TERMINAL ECTODOMAIN | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | DIABETIC DB/DB MICE | Neuroprotective Agents - therapeutic use | Receptors, G-Protein-Coupled - metabolism | Apoptosis - drug effects | Brain Injuries - drug therapy | Humans | Astrocytes - pathology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Drug Discovery - methods | Nerve Growth Factors - metabolism | Brain Ischemia - immunology | Brain Injuries - immunology | Neuroprotective Agents - adverse effects | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Cytokines - immunology | Astrocytes - drug effects | Cell Survival - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects | Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - therapeutic use | Brain Ischemia - drug therapy | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Brain Ischemia - pathology | Brain Injuries - pathology | Astrocytes - metabolism | Drugs | Cytokines | Astrocytes | Macromolecules | Inflammation | Drug development | Neuroprotective agents | Blood | Microglia | Pituitary adenylate cyclase-activating polypeptide | Chemical modification | Neurotransmitters | Side effects | Molecular modelling | Ischemia | Pharmacokinetics | Apoptosis
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 1, p. e0211433
Background PACAP and VIP are closely related neuropeptides with wide distribution and potent effect in the vasculature. We previously reported vasomotor... 
CYCLASE-ACTIVATING POLYPEPTIDE | HORMONE | VASOACTIVE-INTESTINAL-PEPTIDE | CORONARY | PHARMACOLOGICAL CHARACTERIZATION | MULTIDISCIPLINARY SCIENCES | PITUITARY | NEUROPEPTIDE | CEREBRAL-ARTERIES | VIP | EXPRESSION | Carotid Arteries - drug effects | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Insect Proteins - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Nitroprusside - pharmacology | Femoral Artery - drug effects | Mice, Knockout | Animals | Vasoactive Intestinal Peptide - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Carotid Arteries - physiology | Female | Femoral Artery - physiology | Mice | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Vasodilation - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - deficiency | Rats as laboratory animals | Research | Carotid artery | Vasoactive intestinal peptides | Health aspects | Femur | Femoral artery | Neuropeptides | Smooth muscle | Activation | Medical schools | Carotid arteries | Arteries | Vasodilation | Receptors | Rodents | Pituitary adenylate cyclase-activating polypeptide receptors | Physiology | Polypeptides | Migraine | Blood vessels | Gender differences | Anatomy & physiology | Gene expression | Polymerase chain reaction | Pituitary adenylate cyclase-activating polypeptide | Brain research | Isoforms | Females | Veins & arteries
Journal Article
Brain Research, ISSN 0006-8993, 2008, Volume 1241, pp. 29 - 35
Abstract Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are structurally endogenous peptides showing rich... 
Neurology | Schwannoma cells | PACAP | VIP | Apoptosis | SURVIVAL | CYCLASE-ACTIVATING POLYPEPTIDE | HUMAN BRAIN-TUMORS | VASOACTIVE-INTESTINAL-PEPTIDE | HUMAN PITUITARY-ADENOMAS | SPINAL-CORD | NEUROSCIENCES | MESSENGER-RNA | RAT-BRAIN | RECEPTORS | EXPRESSION | Vasoactive Intestinal Peptide - metabolism | Apoptosis - drug effects | Nerve Growth Factors - metabolism | RNA, Messenger - metabolism | Schwann Cells - cytology | Dose-Response Relationship, Drug | Nerve Growth Factors - pharmacology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Vasoactive Intestinal Peptide - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Cell Survival - physiology | bcl-2-Associated X Protein - genetics | RNA, Messenger - drug effects | Schwann Cells - drug effects | Cell Survival - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | bcl-2-Associated X Protein - metabolism | Rats | Schwann Cells - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | bcl-2-Associated X Protein - drug effects | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Proto-Oncogene Proteins c-bcl-2 - drug effects | Cell Line, Tumor | Apoptosis - physiology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasoactive Intestinal Peptide - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Culture Media, Serum-Free - toxicity | Prevention | Adenylate cyclase | Polypeptides | Analysis | Vasoactive intestinal peptides | Gene expression | Index Medicus
Journal Article
Peptides, ISSN 0196-9781, 2007, Volume 28, Issue 9, pp. 1631 - 1639
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2008, Volume 34, Issue 6, pp. 833 - 843
Summary Exposure to chronic stress has been argued to produce maladaptive anxiety-like behavioral states, and many of the brain regions associated with... 
Endocrinology & Metabolism | Psychiatry | Fear | PAC 1 receptor | Corticotropin-releasing hormone | Extended amygdala | Plasticity | Vasoactive intestinal peptide | PAC | receptor | PAC receptor | RAT | PSYCHIATRY | IN-SITU HYBRIDIZATION | SYMPATHETIC NEURONS | NEUROSCIENCES | HYPOTHALAMIC PARAVENTRICULAR NUCLEUS | RECEPTOR-DEFICIENT MICE | NEURITE OUTGROWTH | ENDOCRINOLOGY & METABOLISM | POLYPEPTIDE PACAP | GENE-EXPRESSION | AMYGDALA | Brain-Derived Neurotrophic Factor - genetics | Septal Nuclei - drug effects | Neuronal Plasticity - drug effects | Male | Receptor, trkB - genetics | RNA, Messenger - metabolism | Septal Nuclei - metabolism | Neuronal Plasticity - genetics | Time Factors | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Stress, Psychological - metabolism | Behavior, Animal - drug effects | Brain-Derived Neurotrophic Factor - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Anxiety - metabolism | Stress, Psychological - chemically induced | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Adaptation, Psychological - drug effects | Rats | Behavior, Animal - physiology | Up-Regulation - genetics | Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Rats, Sprague-Dawley | Up-Regulation - drug effects | Stress, Psychological - genetics | Anxiety - genetics | Animals | Models, Biological | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Anxiety - chemically induced | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Chronic Disease | Receptor, trkB - metabolism | Anxiety - etiology | Tyrosine | Adenylate cyclase | Messenger RNA | Polypeptides | ACTH | Hormones | Growth factors | corticotropin-releasing hormone | PAC1 receptor
Journal Article
Journal of headache and pain, ISSN 1129-2369, 12/2018, Volume 19, Issue 1, pp. 1 - 9
textabstractPituitary adenylate cyclase activating polypeptide (PACAP) is an ubiquitous peptide involved, among others, in neurodevelopment, neuromodulation,... 
Neuroprotection | Ischemia | PACAP | Migraine | Neurology | Pain Medicine | Medicine & Public Health | Internal Medicine | MIDDLE CEREBRAL-ARTERY | CYCLASE-ACTIVATING POLYPEPTIDE | NEURONAL CELL-DEATH | BLOOD-BRAIN-BARRIER | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | CLINICAL NEUROLOGY | INDUCED CARDIOMYOCYTE APOPTOSIS | INDUCED RETINAL DEGENERATION | CENTRAL-NERVOUS-SYSTEM | BINDING-SITES | ADENYLATE-CYCLASE | Neuroprotective Agents - therapeutic use | Humans | Brain Ischemia - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Migraine Disorders - drug therapy | Neuroprotective Agents - metabolism | Migraine Disorders - metabolism | Animals | Neuroprotective Agents - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - therapeutic use | Brain Ischemia - drug therapy | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Neurons - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Neurons - drug effects | Care and treatment | Cell receptors | Polypeptides | Development and progression | Genetic aspects | Health aspects | Pituitary adenylate cyclase-activating polypeptide | Headache | Pain perception | PAC1 protein | Therapeutic applications | Neurodevelopment | Neuromodulation
Journal Article